Table 1 Baseline description of 382 women initiating ART during pregnancy, by delay in days from screening to ART initiation

Number of patients

108

382

54

136

61

66

65

--

Median age (IQR)

26 (23–31)

27 (24–31)

29 (24–32)

27 (24–31)

28 (25–32)

27 (25–31)

27 (25–31)

0.965

Median gestation (IQR)

31 (27–34)

27 (23–31)

32 (28–34)

28 (26–32)

27 (23–30)

24 (20–28)

21 (17–25)

<0.001

  <24 weeks

12 (12)

104 (27)

3 (6)

14 (10)

16 (26)

30 (45)

41 (63)

<0.001

  24-28 weeks

25 (24)

134 (35)

12 (22)

57 (42)

26 (43)

21 (32)

18 (28)

  29-32 weeks

33 (31)

94 (25)

19 (35)

40 (29)

14 (23)

15 (23)

6 (9)

  >32 weeks

34 (33)

50 (13)

20 (37)

25 (18)

5 (8)

0

0

WHO stage:  I

67 (62)

206 (55)

25 (48)

83 (62)

38 (62)

34 (52)

26 (40)

0.003

      II

17 (16)

69 (18)

7 (13)

29 (22)

10 (16)

13 (20)

10 (15)

      III

22 (20)

90 (24)

17 (33)

18 (13)

13 (21)

15 (23)

27 (42)

      IV

2 (2)

13 (3)

3 (6)

4 (3)

0

4 (6)

2 (3)

Median CD4 cell count (IQR) *

120 (65–166)

142 (96–186)

139 (85–187)

143 (96–186)

153 (112–210)

133 (104–170)

134 (94–172)

0.538

  CD4 <100 cells/μl

9 (39)

99 (28)

19 (36)

38 (29)

11 (19)

15 (24)

16 (29)

Median HIV Viral load (IQR) *

4.9 (4.6-4.9)

4.3 (3.7-4.8)

4.2 (3.4-4.8)

4.2 (3.8-4.8)

4.4 (3.9-4.9)

4.5 (3.9-4.9)

4.6 (4.1-4.8)

0.211

  >5 log₁₀ copies/mL

3 (15)

55 (15)

9 (17)

17 (13)

8 (14)

13 (21)

8 (15)